Table 1 Patient characteristics according to stroke subtype.

From: The use of brain-specific biomarkers in urine for prediction of neurological outcome and extent of tissue damage following stroke

 

Intracerebral hemorrhage (n = 15)

Acute ischemic stroke (n = 48)

p-value

Age (years)

62 (53–71)

77 (66–83)

0.02

Sex

0.76

 Female

5 (33.3%)

20 (41.7%)

 Male

10 (66.7%)

28 (58.3%)

Diabetes mellitus

3 (%)

10 (%)

0.73

Serum creatinine (mg/dl)

1.02 ± 0.17

2.69 ± 1.53

0.16

Etiology

• Lobar

4 (26.7%)

• Non-lobar (deep or infratentorial)

11 (73.3%)

• Large artery atherosclerosis

14 (29.2%)

• Cardioembolism

23 (47.9%)

• Small artery occlusion

3 (6.25%)

• Other determined cause

1 (2.1%)

• Undetermined cause

7 (14.6%)

 

NIHSS

 At admission

15 (6–19)

11 (5–27)

0.4

 At discharge

12 (1–20), n = 15

4 (2–12), n = 45

0.16

Time from symptom onset to sample collection (hours)*

26 (15–77), n = 12

40 (25–55), n = 37

0.29

Recanalization therapy

Not applicable

• Intravenous thrombolysis

20 (%)

• Mechanical thrombectomy

24 (%)

 

mRS

 Pre-stroke

0 (0–2)

1 (0–2)

0.4

 At discharge

5 (4–5)

4 (2–5)

0.1

 At 3 months

4 (3–6), n = 13

4 (2–5), n = 43

0.5

In-hospital mortality

3 (20%)

4 (8.3%)

0.3

  1. Statistically significant p-values are depicted in a bold font.
  2. NIHSS National Institutes of Health Stroke Scale.
  3. *If precise onset-time was available.